Robotic-assisted Laparoscopic Prostatectomy: Initial Experience of 267 Cases

Journal Title: Üroonkoloji Bülteni - Year 2019, Vol 18, Issue 1

Abstract

Objective: To present our experience of 267 consecutive patients treated with robotic-assisted laparoscopic prostatectomy (RALP) and assess the perioperative and postoperative outcomes. Materials and Methods: Materials and Methods: We retrospectively analyzed the data of 267 men who underwent RALP in our clinic between March 2015 and April 2018. Preoperative clinical data including age, serum prostate-specific antigen (PSA), biopsy Gleason score, and number of positive cores were noted. Perioperative parameters such as operative time and intraoperative complications were recorded. Postoperative parameters including hematocrit change, length of hospital stay, and catheter removal date were noted. Pathological outcomes included pathological Gleason score; positive surgical margin (PSM) status; extracapsular, lymphovascular, perineural, and seminal vesicle invasion; and lymph node positivity. The Clavien-Dindo system was used to classify surgical complications. Results: The mean age of the patients was 64.2±6.4 years and the median PSA was 8.27 ng/dL. The mean operative time was 196.4±59.4 min and median hematocrit decrease was 3.9%. The overall PSM rate was 21.34% and this rate increased significantly with final pathological stage from 12.97% for pT2 to 35.48% for pT3 (p<0.05). Over a mean follow-up time of 19 months, biochemical recurrence occured in 29 patients (9.7%) and a total of 35 patients (22%) required additional treatment. A total of 29 patients (10.86%) had complications and 1 patient required surgical intervention in the first 48 hours after surgery. The median postoperative hospital stay was 3 days and median time to urethral catheter removal was 10 days. Conclusion: Our initial experience with RALP is promising. Oncological outcomes were satisfactory, with patients benefiting from the advantages of the minimally invasive surgical approach.

Authors and Affiliations

Ekrem İslamoğlu, Yasin Aktaş, Özgür Arı, Hakan Anıl, Ali Yıldız, Mutlu Ateş, Murat Savaş

Keywords

Related Articles

Squamous Metaplasia and Its Management in Non-malignant Bladder Diseases

Objective: To reveal possible associations between non-malignant bladder disease and malignancy by evaluating the pathologic examination results of patients who underwent cystectomy for non-malignant diseases and to sugg...

The Role of Imaging in Testicular Cancer Diagnosis, Staging and Follow-up

Although testicular cancer is relatively rare and accounting for approximately 1-1.5% of all cancers in men, it is the most frequent malignancy in young men. Testicular cancer can manifest in a variety of ways. A painles...

Nuclear Medicine Applications in Diagnosis of Urological Tumors

Except for prostate carcinoma, there is limited data in the literature on the role of nuclear imaging methods in the management of urological cancers. 18F-fluorodeoxyglucose positron emission tomography/computed tomograp...

A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis

Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour (TUR-BT) is the standard approach to these patients. Intravesical treatments...

Controversies in Radical Cystectomy: Meta-Analysis and Systemic Comparison of Open Surgery with Laparoscopic and Robotic Surgery

Open radical cystectomy (ORC) is the standard treatment modality in high-risk non-muscle-invasive and invasive bladder carcinoma. Although it has some advantages, oncologic outcomes of ORC are associated with high morbid...

Download PDF file
  • EP ID EP550862
  • DOI 10.4274/uob.galenos.2018.1109
  • Views 84
  • Downloads 0

How To Cite

Ekrem İslamoğlu, Yasin Aktaş, Özgür Arı, Hakan Anıl, Ali Yıldız, Mutlu Ateş, Murat Savaş (2019). Robotic-assisted Laparoscopic Prostatectomy: Initial Experience of 267 Cases. Üroonkoloji Bülteni, 18(1), 14-17. https://europub.co.uk/articles/-A-550862